NAII:NASDAQNatural Alternatives International, Inc. Analysis
Data as of 2026-07-10 - not real-time
$2.24
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at roughly $2.24, which sits below its 20‑day SMA of about $2.42 and the 50‑day SMA of $2.54, signaling a bearish price trend. Momentum indicators are mixed: the RSI is deep in oversold territory at 27, while the MACD line remains below its signal, producing a negative histogram, and volume has been trending lower, suggesting weakening buyer interest. Price is hovering just above the identified support level near $2.21, with resistance around $2.71, and the 30‑day volatility is high at roughly 36%, reflecting a choppy market environment.
Fundamentally, the company shows revenue growth of 23% to $142 M, yet profitability is severely compromised with negative gross, operating, and net margins, and cash flow is negative. The balance sheet is strained, featuring debt of $65 M versus cash of $9 M and a debt‑to‑equity ratio exceeding 100%. Valuation multiples are extremely low (price‑to‑book ~0.22, price‑to‑sales ~0.10) and there is no dividend, while the market’s fear‑greed index is in the “Extreme Greed” zone, indicating heightened speculative sentiment.
Fundamentally, the company shows revenue growth of 23% to $142 M, yet profitability is severely compromised with negative gross, operating, and net margins, and cash flow is negative. The balance sheet is strained, featuring debt of $65 M versus cash of $9 M and a debt‑to‑equity ratio exceeding 100%. Valuation multiples are extremely low (price‑to‑book ~0.22, price‑to‑sales ~0.10) and there is no dividend, while the market’s fear‑greed index is in the “Extreme Greed” zone, indicating heightened speculative sentiment.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages
- RSI indicating oversold conditions but MACD bearish
- Decreasing volume and proximity to support
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained negative earnings and cash flow
- High debt‑to‑equity ratio and limited liquidity
- Low valuation multiples offset by financial distress
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside from low price‑to‑book and price‑to‑sales
- Exposure to growing supplement contract manufacturing market
- Structural balance‑sheet weaknesses requiring turnaround
Key Metrics & Analysis
Financial Health
Revenue Growth23.30%
Profit Margin-10.13%
ROE-20.57%
ROA-2.47%
Debt/Equity103.26
P/B Ratio0.2
Op. Cash Flow$-4505000
Free Cash Flow$-2995125
Technical Analysis
TrendBearish
RSI27.1
Support$2.21
Resistance$2.71
MA 20$2.42
MA 50$2.54
MA 200$2.98
MACDBearish
VolumeDecreasing
Fear & Greed Index92.95
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.74
Volatility35.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.